Do you know how many different types of anti-HER2 therapies are in clinical trials for gastroesophageal adenocarcinoma (GEA)?
Credit available for this activity expires: 02/27/2027
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/breaking-ground-gastroesophageal-adenocarcinoma-first-line-2026a10005tj?ecd=bdc_podcast_libsyn_mscpedu